Extend (Pharmaceuticals and Biotechnology) Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Joint Venture
- Investors
-
3
Extend (Pharmaceuticals and Biotechnology) General Information
Description
Operator of a therapeutic and entrepreneurial initiative intended to create new companies from academic research. The company' specializes in therapeutic areas with unmet medical needs, such as oncology, central nervous system, and rare diseases, using biotechnology-related options such as gene and cell therapy, and monoclonal antibodies, enabling universities, research cntres, and venture-building partners to market for the initiatives for the advancement of research in the biopharmaceutical sector for a variety of major medical problems.
Contact Information
Website
www.extend-tthub.comCorporate Office
- Via Alessandria 220
- 00198 Rome
- Italy
Corporate Office
- Via Alessandria 220
- 00198 Rome
- Italy
Extend (Pharmaceuticals and Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Joint Venture | 28-Oct-2022 | Completed | Generating Revenue |
Extend (Pharmaceuticals and Biotechnology) Signals
Extend (Pharmaceuticals and Biotechnology) Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angelini Ventures | Corporate Venture Capital | Minority | ||
| CDP Venture Capital (Rome) | Venture Capital | Minority | ||
| Evotec | Corporation | Minority |
Extend (Pharmaceuticals and Biotechnology) Investments (1)
Extend (Pharmaceuticals and Biotechnology)’s most recent deal was a Later Stage VC with Resilco for . The deal was made on 12-Mar-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Resilco | 12-Mar-2025 | Later Stage VC | Environmental Services (B2B) |
Extend (Pharmaceuticals and Biotechnology) FAQs
-
When was Extend (Pharmaceuticals and Biotechnology) founded?
Extend (Pharmaceuticals and Biotechnology) was founded in 2021.
-
Where is Extend (Pharmaceuticals and Biotechnology) headquartered?
Extend (Pharmaceuticals and Biotechnology) is headquartered in Rome, Italy.
-
What is the size of Extend (Pharmaceuticals and Biotechnology)?
Extend (Pharmaceuticals and Biotechnology) has 6 total employees.
-
What industry is Extend (Pharmaceuticals and Biotechnology) in?
Extend (Pharmaceuticals and Biotechnology)’s primary industry is Drug Discovery.
-
Is Extend (Pharmaceuticals and Biotechnology) a private or public company?
Extend (Pharmaceuticals and Biotechnology) is a Private company.
-
What is Extend (Pharmaceuticals and Biotechnology)’s current revenue?
The current revenue for Extend (Pharmaceuticals and Biotechnology) is .
-
Who are Extend (Pharmaceuticals and Biotechnology)’s investors?
Angelini Ventures, CDP Venture Capital (Rome), and Evotec have invested in Extend (Pharmaceuticals and Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process